Reduction of endothelial dysfunction following VEGF gene therapy

BACKGROUND/OBJECTIVES: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor. VEGF gene therapy improves perfusion of ischaemic myocardium in experimental models and possibly in patients with end-stage coronary artery disease. In addition to its proliferative and migratory effect o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tio, R.A., Wijpkema, J., Tan, E.S., Asselbergs, F.W., Hospers, G.A.P., Jessurun, G.A.J., Zijlstra, F.
Format: Artigo
Jezik:Inglês
Izdano: 2005
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2497290/
https://ncbi.nlm.nih.gov/pubmed/25696473
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki